Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...

A pilot blood test built on whole-blood mRNA signatures detected nine of ten early-stage pancreatic ductal adenocarcinoma ...

Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

Topline phase 3 SHASTA-3 and SHASTA-4 trial data show plozasiran reduced triglycerides by up to 81% and acute pancreatitis events by 78% in severe HTG.

Technology has granted us the ultimate modern freedom: the ability to conquer darkness.

A new experimental drug may offer hope for pancreatic cancer patients. One of deadliest types of cancer in the United States, an estimated 52,740 Americans will die from the disease this year, ...

Data from a major breakthrough in the fight against pancreatic cancer was released this month, highlighting a new pill that targets the root cause of how the disease exists and spreads. Arizona ...

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...

A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how much. Researchers found that oleic acid—the main fat in olive oil and several ...

An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial. The drug, daraxonrasib, targets the gene mutation ...

A virus has stopped pancreatic cancer in its tracks in three people in a clinical trial in the US. Further evaluation is needed in larger trials, but the early results are encouraging, especially ...

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic cancer Getty Daraxonrasib targets a previously untreatable protein in ...